About

About ELIX About Elix, Inc. Elix is a leading AI drug discovery startup located in Tokyo, Japan. We are on a mission to "Rethink Drug Discovery," consistently aiming to introduce innovative solutions into the realm of pharmaceutical research. Our expertise lies in Elix Discovery™, a state-of-the-art AI platform for small molecules, covering stages from screening hits to lead optimization. Our extensive experience in collaborative AI drug discovery research is reflected in our partnerships with distinguished pharmaceutical companies, research institutes, and universities in Japan, such as Astellas, Shionogi, Kaken, Eisai, Riken, and Kyoto University. With a robust track record in Japan, we are keen to expand our collaborative scope to international partners interested in leveraging our technology. We are dedicated to fostering collaborations with pharma companies, striving to elevate efficiency and success rates through synergy between our revolutionary AI platform, Elix Discovery™, and our partners' wet-lab technologies. We aim to be your most cost-effective and technologically harmonious partner, aligning perfectly with your operational needs. ELiX is a European air-fresheners manufacturer from Wroclaw, Poland, bringing three retail-ready brands to the U.S. aftermarket: ELIX – everyday car & home air fresheners (vent clips, gel cans, fiber hang tags, membrane systems); AROMATONE – premium, long-lasting interior/car perfumes; Amarella™ – fabric & laundry fresheners and crease releasers; plus ODORANO® odor-neutralizing technology. Made in the EU under ISO 9001 & ISO 14001 systems and operating to BRCGS requirements. Products are phthalate-free with full REACH/CLP docs and SDS. ELiX supplies hypermarkets and mass retailers across Europe and the Middle East; we also offer focused Private Label/Contract Manufacturing when required. Looking for EU-made quality and reliable lead times? Let’s build your next fragrance program at AAPEX. Elix is a leading AI drug discovery startup located in Tokyo, Japan. We are on a mission to "Rethink Drug Discovery," consistently aiming to introduce innovative solutions into the realm of pharmaceutical research. Our expertise lies in Elix Discovery™, a state-of-the-art AI platform for small molecules, covering stages from screening hits to lead optimization. Our extensive experience in collaborative AI drug discovery research is reflected in our partnerships with distinguished pharmaceutical companies, research institutes, and universities in Japan, such as Astellas, Shionogi, Kaken, Eisai, Riken, and Kyoto University. With a robust track record in Japan, we are keen to expand our collaborative scope to international partners interested in leveraging our technology. We are dedicated to fostering collaborations with pharma companies, striving to elevate efficiency and success rates through synergy between our revolutionary AI platform, Elix Discovery™, and our partners' wet-lab technologies. We aim to be your most cost-effective and technologically harmonious partner, aligning perfectly with your operational needs.